Galectin-3 is a strong predictor of poor prognosis in the early follow up after surgery in children treated for such congenital heart diseases as a ventricular septal defect, atrioventricular septal defect or pulmonary valve regurgitation after tetralogy of Fallot repair [25]. The gene discussed is LGALS3; the disease is ventricular septal defect.